OnKure Therapeutics (OKUR) Interest & Investment Income (2024 - 2025)
OnKure Therapeutics' (OKUR) quarterly Interest & Investment Income came in at $1.1 million in Q1 2025, up 264.41% on a YoY basis from $295000.0 in Q1 2024, and up 264.41% quarter-over-quarter from $295000.0 in Q1 2024.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Interest & Investment Income (2024 - 2025) Analysis & Trends
OnKure Therapeutics (OKUR) has reported Interest & Investment Income for 2 consecutive years, with $1.1 million the latest figure, recorded in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 36.92 Mn |
| 10 | OnKure Therapeutics | 162.57 Mn | -13.81 Mn | - | - |